SMTL ID : 7o9y.1

Crystal structure of di-phosphorylated human CLK1 in complex with 4-(1H-indol-3-yl)pyrimidin-2-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.66 Å

Oligo State

monomer

Ligands

1 x V5T: 4-(1~{H}-indol-3-yl)pyrimidin-2-amine(Non-covalent)

V5T.1: 10 residues within 4Å: Chain A: V.28, A.42, K.44, E.59, F.94, E.95, L.97, L.148, V.177, D.178 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.28, A:A.42, A:F.94, A:L.97, A:V.177 Hydrogen bonds: A:K.44, A:D.178 Salt bridges: A:E.59, A:D.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Livnah, O. et al., Development of novel CLK1 inhibitors as potential drugs for treatment of Chikungunya virus infections. To Be Published

Release Date

2022-05-04

Peptides

Dual specificity protein kinase CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase CLK1

Related Entries With Identical Sequence